查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1971451

蟲媒病毒檢測市場－全球產業規模、佔有率、趨勢、機會與預測：按檢測類型、最終用戶、地區和競爭格局分類，2021-2031年

Arbovirus Testing Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test Type (RT-PCR Test, ELISA-Test), By End User (Hospitals, Diagnostic Centers), By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球蟲媒病毒檢測市場預計將從 2025 年的 20.7 億美元成長到 2031 年的 29.2 億美元，複合年成長率為 5.91%。

此領域涵蓋診斷檢測和試劑，例如RT-PCR和ELISA試劑盒，旨在識別由蜱蟲和蚊子等節肢動物傳播的感染疾病。推動這一領域成長的主要因素是屈公病、茲卡病毒病和登革熱等媒介傳播感染疾病的發病率不斷上升，而快速的都市化和氣候變遷導致的媒介棲息地擴張進一步加劇了這一趨勢。此外，政府加大對公共衛生監測的投入，並開發旨在透過快速且準確的診斷能力有效控制疫情的早期預警系統，也促進了市場的發展。

市場概覽
預測期 2027-2031
市場規模：2025年 20.7億美元
市場規模：2031年 29.2億美元
複合年成長率：2026-2031年 5.91%
成長最快的細分市場 ELISA檢測
最大的市場 北美洲

然而，該市場面臨一項重大挑戰：血清學檢測中的抗體交叉反應，這常常導致假陽性結果，並阻礙在多種蟲媒病毒共存地區進行準確診斷。這項技術難題凸顯了對能夠區分密切相關病毒株的高特異性診斷設備的迫切需求。根據歐洲疾病預防控制中心 (ECDC) 2024 年發布的數據，「全球報告的登革熱病例超過 1400 萬例，登革熱相關死亡病例超過 1 萬例。」 這些統計數據表明，登革熱給社會帶來了巨大的負擔，並強調了建立強大且擴充性的檢測基礎設施的迫切需求。

市場促進因素

氣候變遷和蚊蟲棲息地擴張導致病原體入侵先前未受感染地區，進而引發全球蟲媒病毒感染疾病激增，這大大刺激了市場需求。日益加重的疾病負擔凸顯了對能夠檢測和識別除傳統流行病之外的新威脅的診斷測試的需求。例如，泛美衛生組織（PAHO）在其2024年12月發布的最新報告《美洲登革熱和奧羅普西熱病例數創歷史新高》中指出，2024年該地區確診的奧羅普西熱病例達11600例，較上年的832例顯著增加。感染率的快速成長迫使衛生部門採購先進的檢測套組以應對複雜的流行病學環境，直接推動了全球診斷產品的消費。

此外，政府加大對公共衛生監測的投入是關鍵驅動力，為檢測設施現代化和防治媒介傳播疾病提供了必要的財政支持。聯邦和國際組織正在投入大量資金，以確保檢測實驗室擁有有效監測和應對疫情所需的設備。根據美國獸醫學院協會（AAVMC）2025年4月發布的公告，美國疾病管制與預防中心（CDC）媒介傳播感染疾病科在2025財政年度獲得了9,060萬美元的預算撥款，用於支持預防和監測活動。這項財政投入在全球範圍內意義重大。核能（IAEA）於2025年10月發布的《2024年度報告》重點介紹了ZODIAC舉措如何為約40家獸醫檢查室配備了用於防治通用感染疾病疫情的診斷設備，並直接創造了對血清學和分子檢測解決方案的持續需求。

市場挑戰

血清學診斷工具固有的交叉反應性是蟲媒病毒檢測產業商業性發展的一大障礙。當檢測無法正確區分抗體和結構相似的病毒時，就會出現這個問題，導致假陽性率居高不下。此類誤差會降低終端用戶的信心，需要額外的確認性檢測，最終導致醫療成本增加和診斷時間延長。因此，在那些需要準確診斷以保障病人安全的地區，快速血清學試劑盒的推廣應用面臨重重困難。

需要進行鑑別診斷的病例數龐大，凸顯了這項挑戰的嚴峻性。根據泛美衛生組織2024年的報告，「美洲報告了超過1,100萬例疑似登革熱病例」。在如此高的發病率下，標準檢測方法無法區分登革熱與其他同時發生的蟲媒病毒，導致診療工作延誤。這種特異性不足限制了現有檢測產品的擴充性，並損害了高需求地區的商機。

市場趨勢

自動化、高通量檢測系統的應用正從根本上改變全球蟲媒病毒檢測市場，打造出能夠應對疫情期間診斷需求激增的臨床實驗室環境。隨著感染率的上升，製造商正致力於開發全自動免疫檢測，以確保最佳化工作流程並快速報告結果，這對於高效的患者照護至關重要。近期監管機構核准的、能夠以最少的人工干預處理海量檢體的系統，凸顯了向高容量基礎設施的轉變。例如，在2025年10月發布的新聞稿《羅氏新型自動化高通量Elecsys登革熱抗原檢測獲得CE認證》中，羅氏宣布其自動化抗原檢測獲得認證，該檢測僅需18分鐘即可出結果，顯著提高了高需求地區的效率。

同時，先進的微流體和生物感測器平台正在解決一個關鍵的產業挑戰：血清學交叉反應。該領域的發展利用創新的微球技術和生物感測介面，能夠準確區分結構相似的黃病毒，例如登革熱病毒和茲卡。這些病毒經常與傳統檢測方法混淆，但先進的平台具有更高的特異性，可以降低假陽性結果的臨床影響，並支持更精準的流行病學監測。例如，北卡羅來納大學教堂山分校在其2025年2月發表的論文《一種能夠準確診斷和監測登革熱病毒和茲卡病毒的新型檢測方法》中報告稱，他們開發的多微球檢測方法在識別既往登革熱感染方面達到了94.9%的靈敏度，同時還能成功將其與茲卡病毒抗體區分開來。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：蟲媒疾病病毒檢測的全球市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依檢測類型（RT-PCR 檢測、ELISA 檢測）
    • 依最終用戶（醫院、診斷中心）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美蟲媒病毒檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲蟲媒病毒檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區蟲媒病毒檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲蟲媒病毒檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲蟲媒病毒檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球蟲媒病毒檢測市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Becton Dickinson & Co
  • bioMerieux SA
  • Abbott Laboratories Inc.
  • Quidel Corporation
  • OraSure Technologies, Inc.
  • Hologic Inc.
  • Cepheid
  • QIAGEN NV
  • F. Hoffmann-La Roche Ltd.
  • Bio-Rad Laboratories, Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 24013

The Global Arbovirus Testing Market is projected to expand from USD 2.07 Billion in 2025 to USD 2.92 Billion by 2031, reflecting a compound annual growth rate of 5.91%. This sector encompasses diagnostic assays and reagents, such as RT-PCR and ELISA kits, designed to identify infections spread by arthropod vectors like ticks and mosquitoes. A primary catalyst for this growth is the rising incidence of vector-borne illnesses, including Chikungunya, Zika, and Dengue, which is further aggravated by rapid urbanization and climate change expanding vector territories. Furthermore, the market is bolstered by increased government investment in public health surveillance and the establishment of early warning systems aimed at effectively managing outbreaks through rapid and precise diagnostic capabilities.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 2.07 Billion
Market Size 2031USD 2.92 Billion
CAGR 2026-20315.91%
Fastest Growing SegmentELISA-Test
Largest MarketNorth America

However, the market faces a significant obstacle regarding the cross-reactivity of antibodies in serological testing, which frequently results in false positives and hinders accurate diagnosis in areas where multiple arboviruses are present simultaneously. This technical shortcoming highlights a critical demand for highly specific diagnostic instruments capable of distinguishing between closely related viral strains. As reported by the 'European Centre for Disease Prevention and Control' in '2024', there were 'over 14 million dengue cases and over 10,000 dengue-related deaths were reported globally', a statistic that underscores the massive disease burden and the imperative for durable, scalable testing infrastructures.

Market Driver

The escalating global prevalence of arboviral infections acts as a major market stimulant, fueled by climate change and the widening reach of mosquito habitats that introduce pathogens to previously unaffected areas. This growing disease burden necessitates diagnostic assays that can detect and differentiate emerging threats beyond standard outbreaks. For example, the Pan American Health Organization noted in a December 2024 update titled 'Americas report record dengue and Oropouche cases' that 11,600 Oropouche cases were documented in the region during 2024, a stark rise from only 832 cases the previous year. Such a sharp increase in infection rates compels health authorities to acquire advanced testing kits to navigate the complex epidemiological environment, thereby directly boosting the global consumption of diagnostic products.

Additionally, increasing government funding for public health surveillance serves as a crucial driver, providing the financial support needed to modernize laboratory facilities and vector control initiatives. Both federal and international organizations are dedicating significant funds to ensure laboratories possess the necessary equipment to monitor and address outbreaks efficiently. According to the American Association of Veterinary Medical Colleges in April 2025, the CDC's Division of Vector-Borne Diseases received appropriations of $90.6 million for the 2025 fiscal year to aid prevention and surveillance efforts. This financial dedication is evident globally; the International Atomic Energy Agency's 'Annual Report 2024', released in October 2025, highlighted that the ZODIAC initiative outfitted nearly 40 veterinary laboratories with diagnostic gear to fight zoonotic outbreaks, directly creating sustained demand for serological and molecular testing solutions.

Market Challenge

The inherent cross-reactivity found in serological diagnostic tools poses a significant barrier to the commercial advancement of the arbovirus testing industry. This issue occurs when assays cannot correctly distinguish between antibodies of structurally analogous viruses, resulting in a high rate of false-positive outcomes. Such inaccuracies diminish end-user trust and require supplementary confirmatory testing, which ultimately increases healthcare costs and prolongs the time required for diagnosis. As a result, the uptake of rapid serological kits faces difficulties in gaining traction in areas where precise diagnosis is essential for patient safety.

The severity of this challenge is emphasized by the massive number of cases that require differentiation. As stated by the 'Pan American Health Organization' in '2024', 'the Region of the Americas reported more than 11 million suspected cases of dengue'. In settings burdened by such high disease rates, the failure of standard tests to separate dengue from other co-circulating arboviruses causes operational delays. This deficiency in specificity restricts the scalability of existing testing products and curtails revenue opportunities in geographical regions with high demand.

Market Trends

The adoption of automated high-throughput laboratory systems is fundamentally reshaping the Global Arbovirus Testing Market by allowing clinical labs to handle the increasing load of diagnostic requests during intense outbreak periods. As transmission rates rise, manufacturers are focusing on creating fully automated immunoassays that optimize workflows and guarantee quick turnaround times, which are vital for efficient patient care. This move towards high-capacity infrastructure is highlighted by recent regulatory clearances for systems capable of processing vast sample quantities with little human involvement; for instance, Roche announced in an October 2025 press release titled 'Roche receives CE mark for novel automated high-throughput Elecsys Dengue Ag test to diagnose dengue' that it obtained certification for an automated antigen test providing results in only 18 minutes, greatly improving efficiency in high-demand areas.

Concurrently, the advancement of sophisticated microfluidic and biosensor platforms is tackling the significant industry hurdle of serological cross-reactivity. Developments in this sector employ innovative microsphere technologies and biosensing interfaces to attain exact differentiation between structurally alike flaviviruses, such as Dengue and Zika, which conventional assays frequently confuse. These advanced platforms deliver superior specificity, decreasing the clinical impact of false positives and aiding more precise epidemiological monitoring. For example, the University of North Carolina at Chapel Hill reported in a February 2025 article, 'New Assay Promises Accurate Diagnosis and Surveillance of Dengue and Zika Viruses', that researchers developed a multiplex microsphere assay achieving 94.9% sensitivity in identifying past dengue infections while successfully distinguishing them from Zika antibodies.

Key Market Players

  • Becton Dickinson & Co
  • bioMerieux SA
  • Abbott Laboratories Inc.
  • Quidel Corporation
  • OraSure Technologies, Inc.
  • Hologic Inc.
  • Cepheid
  • QIAGEN N. V.
  • F. Hoffmann-La Roche Ltd.
  • Bio-Rad Laboratories, Inc.

Report Scope

In this report, the Global Arbovirus Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Arbovirus Testing Market, By Test Type

  • RT-PCR Test
  • ELISA-Test

Arbovirus Testing Market, By End User

  • Hospitals
  • Diagnostic Centers

Arbovirus Testing Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Arbovirus Testing Market.

Available Customizations:

Global Arbovirus Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Arbovirus Testing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Test Type (RT-PCR Test, ELISA-Test)
    • 5.2.2. By End User (Hospitals, Diagnostic Centers)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Arbovirus Testing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Test Type
    • 6.2.2. By End User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Arbovirus Testing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Test Type
        • 6.3.1.2.2. By End User
    • 6.3.2. Canada Arbovirus Testing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Test Type
        • 6.3.2.2.2. By End User
    • 6.3.3. Mexico Arbovirus Testing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Test Type
        • 6.3.3.2.2. By End User

7. Europe Arbovirus Testing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Test Type
    • 7.2.2. By End User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Arbovirus Testing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Test Type
        • 7.3.1.2.2. By End User
    • 7.3.2. France Arbovirus Testing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Test Type
        • 7.3.2.2.2. By End User
    • 7.3.3. United Kingdom Arbovirus Testing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Test Type
        • 7.3.3.2.2. By End User
    • 7.3.4. Italy Arbovirus Testing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Test Type
        • 7.3.4.2.2. By End User
    • 7.3.5. Spain Arbovirus Testing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Test Type
        • 7.3.5.2.2. By End User

8. Asia Pacific Arbovirus Testing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Test Type
    • 8.2.2. By End User
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Arbovirus Testing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Test Type
        • 8.3.1.2.2. By End User
    • 8.3.2. India Arbovirus Testing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Test Type
        • 8.3.2.2.2. By End User
    • 8.3.3. Japan Arbovirus Testing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Test Type
        • 8.3.3.2.2. By End User
    • 8.3.4. South Korea Arbovirus Testing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Test Type
        • 8.3.4.2.2. By End User
    • 8.3.5. Australia Arbovirus Testing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Test Type
        • 8.3.5.2.2. By End User

9. Middle East & Africa Arbovirus Testing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Test Type
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Arbovirus Testing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Test Type
        • 9.3.1.2.2. By End User
    • 9.3.2. UAE Arbovirus Testing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Test Type
        • 9.3.2.2.2. By End User
    • 9.3.3. South Africa Arbovirus Testing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Test Type
        • 9.3.3.2.2. By End User

10. South America Arbovirus Testing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Test Type
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Arbovirus Testing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Test Type
        • 10.3.1.2.2. By End User
    • 10.3.2. Colombia Arbovirus Testing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Test Type
        • 10.3.2.2.2. By End User
    • 10.3.3. Argentina Arbovirus Testing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Test Type
        • 10.3.3.2.2. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Arbovirus Testing Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Becton Dickinson & Co
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. bioMerieux SA
  • 15.3. Abbott Laboratories Inc.
  • 15.4. Quidel Corporation
  • 15.5. OraSure Technologies, Inc.
  • 15.6. Hologic Inc.
  • 15.7. Cepheid
  • 15.8. QIAGEN N. V.
  • 15.9. F. Hoffmann-La Roche Ltd.
  • 15.10. Bio-Rad Laboratories, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer